| 000 | 01538 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514203913.0 | ||
| 264 | 0 | _c20041201 | |
| 008 | 200412s 0 0 eng d | ||
| 022 | _a0021-9746 | ||
| 024 | 7 |
_a10.1136/jcp.2004.016733 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFleming, F J | |
| 245 | 0 | 0 |
_aExpression of SRC-1, AIB1, and PEA3 in HER2 mediated endocrine resistant breast cancer; a predictive role for SRC-1. _h[electronic resource] |
| 260 |
_bJournal of clinical pathology _cOct 2004 |
||
| 300 |
_a1069-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdiagnosis |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHistone Acetyltransferases |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunohistochemistry _xmethods |
| 650 | 0 | 4 | _aMicroscopy, Fluorescence |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNuclear Receptor Coactivator 1 |
| 650 | 0 | 4 | _aNuclear Receptor Coactivator 3 |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xmetabolism |
| 650 | 0 | 4 |
_aTranscription Factors _xanalysis |
| 700 | 1 | _aMyers, E | |
| 700 | 1 | _aKelly, G | |
| 700 | 1 | _aCrotty, T B | |
| 700 | 1 | _aMcDermott, E W | |
| 700 | 1 | _aO'Higgins, N J | |
| 700 | 1 | _aHill, A D K | |
| 700 | 1 | _aYoung, L S | |
| 773 | 0 |
_tJournal of clinical pathology _gvol. 57 _gno. 10 _gp. 1069-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/jcp.2004.016733 _zAvailable from publisher's website |
| 999 |
_c15144612 _d15144612 |
||